Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | SELP | P16109 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19199205 | 1.00 | CNR1 (0.57) | CNR1CNR2SELPFAAHALDH1A1 | |
| SCHEMBL27997036 | 1.00 | CNR1 (0.57) | CNR1CNR2SELPFAAHALDH1A1 | |
| SCHEMBL24826063 | 0.92 | CNR1 (0.52) | CNR1CNR2SELPFAAHALDH1A1 | |
| SCHEMBL16390142 | 0.91 | CNR1 (0.49) | CNR1CNR2SELPFAAHALDH1A1 | |
| SCHEMBL425951 | 0.90 | ALDH1A1 (0.55) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL10345306 | 0.89 | NAMPT (0.52) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL10660707 | 0.89 | NAMPT (0.52) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL24818366 | 0.89 | NAMPT (0.52) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL10345059 | 0.89 | NAMPT (0.52) | CNR1CNR2FAAHALDH1A1HPGD | |
| SCHEMBL23471810 | 0.86 | ALDH1A1 (0.50) | CNR1CNR2FAAHALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102914-A | Environment-friendly water-borne wood coating gloss regulator and preparation method thereof | 贵州正业龙腾新材料开发有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-109875963-A | A kind of ceftriaxone injection and preparation method thereof | 上海欣峰制药有限公司 | 2019-06-14 | — | — | CN | claimed |
| US-8350080-B2 | Method for the production of acyl glycinates by means of direct oxidation | CLARIANT FINANCE (BVI) LIMITED (BV) | 2013-01-08 | — | — | US | claimed |
| EP-2061737-B1 | PROCESS FOR PREPARING ACYLGLYCINATES BY MEANS OF DIRECT OXIDATION | CLARIANT FINANCE BVI LTD (VG) | 2012-10-10 | — | — | EP | claimed |
| US-8093414-B2 | Process for preparing acylglycinates by means of direct oxidation | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-01-10 | — | — | US | claimed |
| EP-2250147-B1 | METHOD FOR THE PRODUCTION OF ACYL GYLCINATES BY MEANS OF DIRECT OXIDATION | CLARIANT FINANCE BVI LTD (VG) | 2011-10-12 | — | — | EP | claimed |
| CN-101553559-B | Compound (I) | CRODA UNIQEMA INC | 2011-07-27 | — | — | CN | claimed |
| US-20100305358-A1 | Method For The Production Of Acyl Glycinates By Means Of Direct Oxidation | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-12-02 | — | — | US | claimed |
| US-20100286418-A1 | Process For Preparing Acylglycinates By Means Of Direct Oxidation | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-11-11 | — | — | US | claimed |
| CN-101553559-A | Compound (I) | CRODA UNIQEMA INC (US) | 2009-10-07 | — | — | CN | claimed |
| CN-1272419-C | Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants | ICI AMERICALS INC (US) | 2006-08-30 | — | — | CN | claimed |
| US-20050053681-A1 | Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds | ICI AMERICAS, INC. (US) | 2005-03-10 | — | — | US | claimed |
| JP-2004535416-A | — | — | 2004-11-25 | — | — | JP | claimed |
| CN-1535309-A | Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants | ICI | 2004-10-06 | — | — | CN | claimed |
| EP-1392116-A1 | SOLUTIONS OF ALKOXYLATED ALKANOL AMIDE SURFACTANTS AND ANTIMICROBIAL COMPOUNDS | ICI Americas Inc. (US) | 2004-03-03 | — | — | EP | claimed |
| US-20030165429-A1 | Method for measuring skin absorbability of a substance | SHISEIDO CO., LTD. | 2003-09-04 | — | — | US | claimed |
| US-20030091667-A1 | Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds | ICI UNIQEMA, INC. | 2003-05-15 | — | — | US | claimed |
| WO-2002098222-A1 | SOLUTIONS OF ALKOXYLATED ALKANOL AMIDE SURFACTANTS AND ANTIMICROBIAL COMPOUNDS | ICI AMERICAS INC. (US) | 2002-12-12 | — | — | WO | claimed |
| EP-1096255-A2 | Method for measuring skin absorbability | SHISEIDO COMPANY LIMITED (JP) | 2001-05-02 | — | — | EP | claimed |
| US-3933709-A | ALKYLPHENOXY POLYETHYLENE GLYCOL, AMINE OR QUATERNARY AMMONIUM SALT, AMIDE | TECHNICAL PROCESSING, INC. (US) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091667-A1 | Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds | AP3S1, SMURF1, CUTA | CNR1 367/4885CNR2 287/4885SELP 3922/4885 |
| US-20100286418-A1 | Process For Preparing Acylglycinates By Means Of Direct Oxidation | FADS1, UGCG, AGPAT2 | CNR1 1061/4885CNR2 987/4885SELP 3171/4885 |
| US-20050053681-A1 | Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds | CUTA, SMURF1, H1-0 | CNR1 627/4885CNR2 467/4885SELP 3852/4885 |
| US-20100305358-A1 | Method For The Production Of Acyl Glycinates By Means Of Direct Oxidation | ACOX1, ACOX3, ACADM | CNR1 1784/4885CNR2 1685/4885SELP 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.